HUE047692T2 - Gyógyászati készítmények és eljárások stabilizálásukra - Google Patents

Gyógyászati készítmények és eljárások stabilizálásukra

Info

Publication number
HUE047692T2
HUE047692T2 HUE09803270A HUE09803270A HUE047692T2 HU E047692 T2 HUE047692 T2 HU E047692T2 HU E09803270 A HUE09803270 A HU E09803270A HU E09803270 A HUE09803270 A HU E09803270A HU E047692 T2 HUE047692 T2 HU E047692T2
Authority
HU
Hungary
Prior art keywords
stabilizing
methods
same
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
HUE09803270A
Other languages
English (en)
Inventor
Rajeshwar Motheram
Gopal Krishna
Ding Min
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of HUE047692T2 publication Critical patent/HUE047692T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE09803270A 2008-08-01 2009-07-30 Gyógyászati készítmények és eljárások stabilizálásukra HUE047692T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8559408P 2008-08-01 2008-08-01
US9381008P 2008-09-03 2008-09-03

Publications (1)

Publication Number Publication Date
HUE047692T2 true HUE047692T2 (hu) 2020-05-28

Family

ID=41610652

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE09803270A HUE047692T2 (hu) 2008-08-01 2009-07-30 Gyógyászati készítmények és eljárások stabilizálásukra

Country Status (21)

Country Link
US (4) US20100105743A1 (hu)
EP (1) EP2320739B1 (hu)
JP (4) JP2011529879A (hu)
KR (4) KR20160095206A (hu)
CN (2) CN102186351A (hu)
AU (1) AU2009277100B2 (hu)
BR (1) BRPI0917562B8 (hu)
CA (1) CA2732692C (hu)
CY (1) CY1122526T1 (hu)
DK (1) DK2320739T3 (hu)
EA (1) EA201170287A1 (hu)
ES (1) ES2770178T3 (hu)
HR (1) HRP20200136T1 (hu)
HU (1) HUE047692T2 (hu)
LT (1) LT2320739T (hu)
MX (1) MX2011001241A (hu)
NZ (1) NZ591204A (hu)
PL (1) PL2320739T3 (hu)
PT (1) PT2320739T (hu)
SI (1) SI2320739T1 (hu)
WO (1) WO2010014234A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120100945A (ko) * 2009-09-30 2012-09-12 마이크로도스 테라퓨특스, 인코포레이티드 레이노 증후군의 치료를 위한 방법들 및 조성물들
HUE026295T2 (hu) 2010-10-12 2016-06-28 The Medicines Co Clevidipin emulzió formulálások, amelyek antimikrobiális szereket tartalmaznak
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
BR112013025368A8 (pt) * 2011-04-01 2018-06-12 The Medicines Co Medicamento, método para preparar um medicamento útil para reduzir danos por derrame em um sujeito com derrame, método para preparar um medicamento útil para reduzir a pressão sanguínea e reduzir danos por derrame em um sujeito com derrame
CN103134891A (zh) * 2011-11-30 2013-06-05 天津金耀集团有限公司 一种丁酸氯维地平含量和有关物质的测定方法
EA030354B1 (ru) 2012-10-26 2018-07-31 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способ уменьшения диспноэ у пациента с острой сердечной недостаточностью
CN103520104B (zh) * 2013-10-25 2015-08-26 北京蓝丹医药科技有限公司 丁酸氯维地平脂肪乳注射液及其制备方法
CN109776405A (zh) * 2019-03-07 2019-05-21 重庆安格龙翔医药科技有限公司 一种丁酸氯维地平杂质的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756779A (fr) * 1969-09-30 1971-03-01 Warner Lambert Pharmaceutical Solutions stables de cardenolides sensibles a l'oxydation
US4150744A (en) * 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
US5651991A (en) * 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
SE9303744D0 (sv) * 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
SE9804002D0 (sv) 1998-11-23 1998-11-23 Astra Ab New manufacturing process
JP2000247883A (ja) * 1999-02-23 2000-09-12 Fujisawa Pharmaceut Co Ltd ジヒドロピリジン系化合物を含有する内服用液剤
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
US6956048B2 (en) * 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US6680334B2 (en) * 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
JP2003104888A (ja) * 2001-09-28 2003-04-09 Taiyo Yakuhin Kogyo Kk ジヒドロピリジン誘導体の錠剤
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
ES2294330T3 (es) * 2002-08-02 2008-04-01 MERCK & CO., INC. Derivados de furo(2,3-b)piridina sustituidos.
EP1635773A2 (en) * 2003-06-06 2006-03-22 Merck & Co., Inc. (a New Jersey corp.) Combination therapy for the treatment of hypertension
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
JP4509118B2 (ja) * 2004-10-06 2010-07-21 エルメッド エーザイ株式会社 医薬組成物及びその製造方法、並びに医薬組成物におけるジヒドロピリジン系化合物の安定化方法
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
BRPI0614417A2 (pt) * 2005-07-28 2011-03-29 Reliant Pharmaceuticals Inc composições farmacêuticas compreendendo bloqueadores de canais de cálcio de dihidropiridina e ácidos graxos de Èmega-3 e métodos de tratamento utilizando as mesmas
CN101484006A (zh) * 2006-04-18 2009-07-15 Ekr治疗公司 预混和的、立即可用的ⅳ推注组合物和使用方法

Also Published As

Publication number Publication date
CA2732692C (en) 2019-12-24
KR20170051542A (ko) 2017-05-11
SI2320739T1 (sl) 2020-03-31
ES2770178T3 (es) 2020-06-30
KR20160095206A (ko) 2016-08-10
JP2016216501A (ja) 2016-12-22
DK2320739T3 (da) 2020-02-24
CA2732692A1 (en) 2010-02-04
JP2015098472A (ja) 2015-05-28
EA201170287A1 (ru) 2011-10-31
JP2011529879A (ja) 2011-12-15
HRP20200136T1 (hr) 2020-08-21
BRPI0917562B8 (pt) 2021-05-25
EP2320739B1 (en) 2019-11-27
NZ591204A (en) 2013-02-22
US20100105743A1 (en) 2010-04-29
PL2320739T3 (pl) 2020-06-01
KR20180059956A (ko) 2018-06-05
CY1122526T1 (el) 2021-01-27
KR101946977B1 (ko) 2019-05-21
JP6537538B2 (ja) 2019-07-03
AU2009277100A1 (en) 2010-02-04
CN102186351A (zh) 2011-09-14
US20190117660A1 (en) 2019-04-25
LT2320739T (lt) 2020-01-27
MX2011001241A (es) 2011-08-03
US20230302002A1 (en) 2023-09-28
BRPI0917562A2 (pt) 2017-06-20
PT2320739T (pt) 2020-02-18
BRPI0917562A8 (pt) 2017-12-12
US20120322836A1 (en) 2012-12-20
JP2017081980A (ja) 2017-05-18
EP2320739A4 (en) 2011-08-24
CN106377501A (zh) 2017-02-08
BRPI0917562B1 (pt) 2021-04-06
AU2009277100B2 (en) 2015-05-28
KR20110059843A (ko) 2011-06-07
WO2010014234A1 (en) 2010-02-04
EP2320739A1 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
IL216254A (en) Compounds, pharmaceutical compositions and their uses
IL228817A0 (en) Pharmaceutical compounds
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0814695D0 (en) Pharmaceutical compositions
HK1158528A1 (zh) 藥物製劑
EP2265731A4 (en) METHODS AND COMPOSITION FOR EVALUATING MEDICATION RESPONSE
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
IL216768A0 (en) Aminopyrrolidinone derivatives compositions comprising the same and uses thereof
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
PL2323623T3 (pl) Kompozycje farmaceutyczne
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL210226A (en) Azul compound and pharmaceutical preparations containing them
HUE047692T2 (hu) Gyógyászati készítmények és eljárások stabilizálásukra
IL208387A0 (en) Pharmaceutical composition
HK1156844A1 (en) Pharmaceutical composition 271 271
IL203064B (en) A pharmaceutical preparation containing compound 11 - deoxy - prostaglandin and a method for stabilizing the compound
HK1145837A1 (en) Amide derivative and pharmaceutical composition containing the same
ZA201006224B (en) Pharmaceutical composition
EP2327406A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION
GB2464200B (en) Pharmaceutical composition
IL206487A0 (en) Pharmaceutical compositions
PL2379056T3 (pl) Stała kompozycja farmaceutyczna zawierająca co najmniej jeden środek stabilizujący
GB0817969D0 (en) Pharmaceutical composition
GB0800659D0 (en) Pharmaceutical Compositions
TWI365071B (en) Isoxazole derivatives and pharmaceutical compositions comprising the same